Researchers from UConn's College of Agriculture, Health and Natural Resources (CAHNR) and College of Liberal Arts and ...

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, ...

By Apoorva Mandavilli The technology that powered Covid vaccines may also lead scientists to a cure for H.I.V. Using mRNA, Australian researchers said they were able to trick the virus to come out of ...

In the quest to design vaccines that better help the body's immune system fight disease, scientists are always looking for ...

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a new study.

A new type of mRNA vaccine is more adaptable to mutating viruses like SARS-CoV-2 and the bird flu, according to research from ...

Downstream processing for mRNA manufacturing is currently too complex, but simplifying by using precipitation looks promising.

The Federal Circuit upheld a ruling that Moderna's COVID-19 vaccine does not infringe Alnylam's mRNA patents related to the SM-102 lipid used in Spikevax.

TriLink BioTechnologies, a provider of life science reagents and services, has signed a non-exclusive License and Supply ...

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine ... Worldwide, flu leads to 3 to 5 million cases of severe illness and 290,000-650,000 respiratory ...